ZymoGenetics Financial Statements
ZymoGenetics Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
| Annual Report | Company Web Site |
| Investor Relations | Company Web Site |
This data is provided as per license from EDGAR Online
ZymoGenetics Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 38.5 | 25.4 | 42.9 |
| Gross Profit ($ mil.) | -- | -- | -- |
| Operating Income ($ mil.) | (150.8) | (136.3) | (80.0) |
| Total Net Income ($ mil.) | (148.1) | (130.0) | (78.0) |
| Diluted EPS (Net Income) | (2.17) | (1.94) | (1.28) |
ZymoGenetics Quarterly Statements
| Quarter Ending Jun 08 | Quarter Ending Mar 08 | Quarter Ending Dec 07 | |
|---|---|---|---|
| Revenue ($ mil.) | 12.6 | 13.5 | 20.5 |
| Gross Profit ($ mil.) | 12.4 | 13.4 | -- |
| Operating Income ($ mil.) | (36.6) | (40.5) | (38.9) |
| Total Net Income ($ mil.) | (37.4) | (40.9) | (38.6) |
| Diluted EPS (Net Income) | (0.54) | (0.60) | (0.56) |
ZymoGenetics Stock Quote & Chart
10/15/08 15:00:09 EST •
NASDAQ •
4.64
•
 -0.3800
•
-7.5697 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
ZymoGenetics Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 10.52 | 3.75 | 1.56 |
| Price/Earnings Ratio | -- | 16.34 | 15.82 |
| Price/Book Ratio | 11.08 | 2.92 | 1.52 |
| Price/Cash Flow Ratio | -- | 13.17 | 9.88 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed ZymoGenetics Financial Ratios
ZymoGenetics Competitive Intelligence
| Baxter | Ethicon | King Pharmaceuticals | |
|---|---|---|---|
| Annual Sales ($ mil.) | 11,263.0 | 3,101.0 | 2,136.9 |
| Employees | 46,000 | 11,000 | 2,052 |
| Market Cap ($ mil.) | 43,566.0 | -- | 2,756.4 |
Competitive Landscape
